Showing results (471-480 of 500) with videos related to
Sort By:
Pageof 50
Journal of Hepatology|November 28, 2006
Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infectionJie Zhou, Liwei Lu, Man-Fung Yuen, et al.Journal of Virology|December 5, 2022
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike ProteinYuliu Chen, Yan Wu, Shaoying Chen, et al.Nature Communications|March 22, 2021
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2Hanjun Zhao, Kelvin K W To, Hoiyan Lam, et al.Journal of Virology|August 4, 2019
Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus InfectionYanling Wu, Jing Xue, Chunyu Wang, et al.Signal Transduction and Targeted Therapy|July 30, 2021
Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluationShuai Xia, Qiaoshuai Lan, Yun Zhu, et al.Cellular & Molecular Immunology|March 5, 2024
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivitySuiyi Tan, Wenjuan Li, Chan Yang, et al.Nature|March 27, 2025
STING agonist-based ER-targeting molecules boost antigen cross-presentationXiafeng Wang, Zhangping Huang, Lixiao Xing, et al.Signal Transduction and Targeted Therapy|February 14, 2024
Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytesXinyi Yang, Xu Zheng, Yuqi Zhu, et al.Cellular & Molecular Immunology|February 2, 2019
Sin1/mTORC2 regulate B cell growth and metabolism by activating mTORC1 and MycMan Li, Adam S Lazorchak, Xinxing Ouyang, et al.Cell|March 28, 2022
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibodyCheng Li, Wuqiang Zhan, Zhenlin Yang, et al.Pageof 50